Amoeba Stock: Shares Surge by 3.7%
Amoeba stock has significantly advanced this Thursday morning, trading at 1.008 euros, marking a 3.7% increase from the previous day. The stock of the Lyon-based company, specializing in biocontrol, thus exceeds the symbolic threshold of 1 euro, amid a bullish trend that has been developing over several weeks.
Technical Indicators Show Positive Signals
Having settled at 1.008 euros, Amoeba is now trading above all its key moving averages: the 50-day moving average is at 0.96 euros, and the 200-day moving average is at 0.98 euros. This dual crossover is a closely watched technical signal, as it indicates a reversal of the medium and long-term trend in favor of buyers. The stock had fluctuated below these levels for much of the past few months. The Relative Strength Index (RSI), which measures the relative strength of the ongoing movement, stands at 62, a level that reflects buying pressure without signaling an overbought zone. The stock is also positioned above its upper Bollinger band (0.98 euros), which may indicate a short-term acceleration of the bullish movement. The main resistance threshold identified at 0.98 euros has been clearly surpassed during this session.
Recent Performance Overview
Over the past week, Amoeba stock has recorded a gain of 6.11%, while the performance over three months has reached 3.49%. Over a one-year horizon, the cumulative progression stands at 13.39%, reflecting a gradual recovery of the stock after a long period of weakness. The stock's beta is -0.11, indicating that it moves very weakly correlated—or even inversely—to the overall market. This characteristic can be explained by the small size of the market capitalization and the specific nature of Amoeba's business, which is focused on the niche segment of biological water treatment solutions and biocontrol. The volatility measured over one month is established at 8.08, a moderate level for a stock of this profile.
